Showing results (61-70 of 149) with videos related to
Sort By:
Pageof 15
Journal of Medicinal Chemistry|June 9, 2015
Structure-activity study of N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652), a bitopic ligand that acts as a negative allosteric modulator of the dopamine D2 receptorJeremy Shonberg, Christopher Draper-Joyce, Shailesh N Mistry, et al.Molecular Pharmacology|June 27, 2013
Reverse engineering of the selective agonist TBPB unveils both orthosteric and allosteric modes of action at the M₁ muscarinic acetylcholine receptorPeter Keov, Celine Valant, Shane M Devine, et al.Plos One|February 21, 2015
Screening the Medicines for Malaria Venture "Malaria Box" against the Plasmodium falciparum aminopeptidases, M1, M17 and M18Alessandro Paiardini, Rebecca S Bamert, Komagal Kannan-Sivaraman, et al.Journal of Medicinal Chemistry|May 27, 2014
Synthesis and pharmacological evaluation of analogues of benzyl quinolone carboxylic acid (BQCA) designed to bind irreversibly to an allosteric site of the M ₁ muscarinic acetylcholine receptorBriana J Davie, Celine Valant, Jonathan M White, et al.Pharmaceutics|December 28, 2019
Ionic Liquid Forms of the Antimalarial Lumefantrine in Combination with LFCS Type IIIB Lipid-Based Formulations Preferentially Increase Lipid Solubility, In Vitro Solubilization Behavior and In Vivo ExposureErin Tay, Tri-Hung Nguyen, Leigh Ford, et al.ACS Chemical Neuroscience|December 14, 2021
Structural Features of Iperoxo-BQCA Muscarinic Acetylcholine Receptor Hybrid Ligands Determining Subtype Selectivity and EfficacyMatthew C L Wakeham, Briana J Davie, David K Chalmers, et al.Bioorganic & Medicinal Chemistry|September 16, 2009
3- and 6-Substituted 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]pyridines as A1 adenosine receptor allosteric modulators and antagonistsLuigi Aurelio, Celine Valant, Heidi Figler, et al.The Journal of Biological Chemistry|August 30, 2008
A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligandCeline Valant, Karen J Gregory, Nathan E Hall, et al.RSC Advances|May 2, 2022
API ionic liquids: probing the effect of counterion structure on physical form and lipid solubilityLeigh Ford, Erin Tay, Tri-Hung Nguyen, et al.Journal of Medicinal Chemistry|December 10, 2014
Synthesis and pharmacological evaluation of dual acting ligands targeting the adenosine A2A and dopamine D2 receptors for the potential treatment of Parkinson's diseaseManuela Jörg, Lauren T May, Frankie S Mak, et al.Pageof 15